This dataset contains data about clinical trials funded by the California Institute for Regenerative Medicine (CIRM), including the award value (i.e., trial cost) down to the specific dollar amount, phase of the clinical trial, targeted enrollment (i.e., number of patients), and disease area. These trials are related to stem cell-based treatments. This data is publicly available and was initially collected by KEI on June 2019 using the www.cirm.ca.gov website, and updated on September 2019 and January 2020. KEI will continue to update this data periodically as more information about CIRM grants becomes available.

Source: https://www.cirm.ca.gov/clinical-trials?tab=bloodcancers#clinicaltrials